To include your compound in the COVID-19 Resource Center, submit it here.

Biogen CEO Scangos departing

Biogen Inc. (NASDAQ:BIIB) gained $20.04 to $282.45 on Thursday after disclosing strong 2Q16 financial results and saying CEO George Scangos will depart "in the coming months" after

Read the full 276 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE